TACC2 and breast cancer: On the other hand, single‐nucleotide polymorphisms (SNPs) in TACC2 were significantly associated with a risk of low‐grade breast cancer 25, and TACC2 mRNA expression was significantly correlated with shorter disease‐free survival of breast carcinomas patients 12.